Jump to content
RemedySpot.com

*MS Drug Study* Note*

Rate this topic


Guest guest

Recommended Posts

Guest guest

Hi

This was posted to another list. it may only be for those living in

the US though? I know only what is written below. Adam:

he CLARITY Study

It’s about the freedom to choose the treatment that works best for

you. That’s why researchers are studying an oral form of an

investigational medicine (a tablet) to determine whether it is safe

and effective in treating relapsing-remitting multiple sclerosis.

The CLARITY Study is a double-blind clinical trial of an

investigational oral medicine (Cladribine) in the treatment of

relapsing-remitting multiple sclerosis. Certain forms of Cladribine

are approved for use in other illnesses, but research is still needed

on treating Multiple Sclerosis with Cladribine tablets.

Find out now if you can take part

Click here to answer a short series of questions to help determine

whether you can take part in this study. You are under no obligation

to participate, and all information you submit will be held in

confidence. For your participation in this short survey, you will be

entered into our sweepstakes which awards multiple cash prizes

totaling $10,000 each month:

http://www.surveyspot.com/welcome.jsp?sid=117810 & suID=1525771842

You will be under no obligation to participate, and the information

you submit will be held in confidence. If you have questions about

this survey, please reference survey number 606939.

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...